Hybrid Conferencee

International Conference on Cancer Pathology (ICCPATH - 27)

26th - 27th March 2027 | London, UK
Sample Abstract
Download
Conference Brochure
Sample Full Paper
Download
Conference Programme

Tentative Conference Agenda

Explore the proposed two-day programme developed around the conference Session Tracks and aligned United Nations Sustainable Development Goals.

Conference Format Hybrid Conference In-person and virtual participation
Programme 2 Days 26–27 March 2027
Academic Scope 11 Tracks Conference Session Tracks
Research Scope 20 Areas Call for Papers themes
SDG Alignment 3 SDGs SDGs 3, 4 and 9
Tentative Agenda & Timings

Session timings, sequence, track grouping and allocations are tentative and subject to change. Final timings will be confirmed closer to the conference. All timings follow the local time of the conference location.

Day 01

Opening, Keynote & Technical Sessions

26 MAR 2027 HYBRID
  1. 09:00 AM 09:30 AM

    Registration, Welcome Kit Collection & Virtual Check-in

    Participant arrival, credential verification and virtual lobby access.

    HYBRID
  2. 09:30 AM 09:45 AM

    Networking Tea & Digital Welcome

    Informal networking for on-site and virtual participants.

    HYBRID
  3. 09:45 AM 10:30 AM

    Welcome Address, Opening Plenary & Keynote Presentation I

    Opening of the conference and introduction to its research focus.

    PLENARY
  4. 10:30 AM 12:30 PM

    Concurrent Technical Session I

    3 TRACKS
    Track 01
    Advancements in Cancer Diagnostics
    34
    Track Overview

    This track will explore the latest innovations in cancer diagnostic techniques, focusing on the integration of histopathology and molecular oncology. Emphasis will be placed on the role of advanced imaging and biomarker discovery in enhancing diagnostic accuracy.

    Track 02
    Tumor Markers: Clinical Applications and Challenges
    39
    Track Overview

    This session will examine the clinical utility of tumor markers in cancer diagnosis and monitoring. Discussions will include the challenges associated with the specificity and sensitivity of these biomarkers in various cancer types.

    Track 03
    Immunohistochemistry in Cancer Pathology
    39
    Track Overview

    This track will delve into the applications of immunohistochemistry in the characterization of tumors. Participants will discuss the latest techniques and their implications for personalized medicine.

  5. 12:30 PM 01:30 PM

    Lunch & Networking Break

    Refreshment interval and networking opportunity.

    BREAK
  6. 01:30 PM 03:30 PM

    Concurrent Technical Session II

    3 TRACKS
    Track 04
    Molecular Oncology: Pathways and Targets
    39
    Track Overview

    This session will focus on the molecular mechanisms underlying cancer pathogenesis and the identification of novel therapeutic targets. Researchers will present findings on signaling pathways and their relevance to tumor biology.

    Track 05
    Translational Research in Cancer Pathology
    34
    Track Overview

    This track will highlight the importance of translational research in bridging laboratory findings with clinical applications. Presentations will cover recent breakthroughs that have the potential to impact patient care.

    Track 06
    Histopathological Techniques and Innovations
    39
    Track Overview

    This session will showcase cutting-edge histopathological techniques that enhance the understanding of cancer morphology. Participants will discuss the implications of these innovations for diagnostic pathology.

  7. 03:30 PM 04:00 PM

    Interactive Q&A, Day 1 Summary & Group Photo

    Closing interaction and key takeaways from the first day.

    CLOSING
Day 02

Keynote, Technical Sessions & Awards

27 MAR 2027 HYBRID
  1. 09:00 AM 09:15 AM

    Participant Check-in & Day 2 Welcome

    On-site attendance confirmation and virtual lobby access.

    HYBRID
  2. 09:15 AM 10:00 AM

    Keynote Presentation II

    Expert address on the future of the conference research domain.

    PLENARY
  3. 10:00 AM 12:00 PM

    Concurrent Technical Session III

    3 TRACKS
    Track 07
    Clinical Trials: Emerging Therapies in Oncology
    34
    Track Overview

    This track will focus on the design and outcomes of recent clinical trials evaluating novel cancer therapies. Discussions will include the role of pathology in trial design and patient stratification.

    Track 08
    Biomarker Discovery: Challenges and Opportunities
    34
    Track Overview

    This session will explore the current landscape of biomarker discovery in cancer research. Participants will discuss the methodologies employed and the potential for biomarkers to revolutionize cancer treatment.

    Track 09
    Disease Mechanisms in Cancer Progression
    39
    Track Overview

    This track will investigate the underlying mechanisms that drive cancer progression and metastasis. Researchers will present their findings on genetic, epigenetic, and environmental factors influencing disease outcomes.

  4. 12:00 PM 01:00 PM

    Lunch & Networking Break

    Refreshment interval and professional networking.

    BREAK
  5. 01:00 PM 03:00 PM

    Concurrent Technical Session IV

    2 TRACKS
    Track 10
    Integrative Approaches in Cancer Pathology
    34
    Track Overview

    This session will emphasize the importance of integrative approaches combining histopathology, genomics, and proteomics in understanding cancer. Discussions will focus on how these multidisciplinary strategies can enhance diagnostic and therapeutic outcomes.

    Track 11
    Future Directions in Cancer Pathology Research
    34
    Track Overview

    This track will provide a platform for discussing future research directions in cancer pathology. Participants will explore emerging trends, technologies, and collaborative efforts aimed at advancing the field.

  6. 03:00 PM 03:30 PM

    Publications, Best Paper & Best Presentation Awards

    Publication guidance and recognition of outstanding research contributions.

    AWARDS
  7. 03:30 PM 04:00 PM

    Valedictory Session, Closing Remarks & Group Photo

    Conference summary, acknowledgements and formal conclusion.

    CLOSING
Aligned SDGs
3 Good Health and Well-being 4 Quality Education 9 Industry, Innovation and Infrastructure

Be Part of ICCPATH-27

Submit your research or complete your conference registration.